课题基金 / 基金详情

Low dose ColchicinE in pAtients with peripheral artery DiseasE to address residual vascular Risk (LEADER-PAD): A multinational randomized trial

Low dose ColchicinE in pAtients with peripheral artery DiseasE to address residual vascular Risk (LEADER-PAD): A multinational randomized trial
低剂量秋水仙素治疗外周动脉疾病患者以解决残余血管风险 (LEADER-PAD)：一项多国随机试验
批准号：
478044
负责人：
Chan Noel
金额：
$293.06万
依托单位：
McMaster University
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2023
资助国家：
加拿大
项目状态：
未结题
起止时间：
2023-03-01 至 2028-03-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=478044&lang=en
关键词：
Anti Inflammatory Therapy Atherosclerosis Colchicine Leg Amputation Mortality Myocardial Infarction Peripheral Artery Disease Randomized Controlled Trial Stroke

项目摘要

项目成果

Chan Noel的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Conditions that impact blood vessels and the heart, cause about 18 million deaths each year. One such condition, that is not often discussed, is peripheral artery disease (PAD). PAD is caused by the accumulation of fatty deposits within an inflamed artery
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Low dose ColchicinE in pAtients with peripheral artery DiseasE to address residual vascular Risk (LEADER-PAD): A multinational randomized trial
  • 批准号：
    467630
  • 项目类别：
    Operating Grants
  • 资助金额：
    $7.29万
  • 财政年份：
    2022
  • 负责人：
    Chan Noel
  • 依托单位：
    McMaster University
Low dose ColchicinE in pAtients with peripheral Artery DiseasE to address residual vascular Risk (LEADER-PAD): A randomized trial (Vanguard Phase)
  • 批准号：
    434730
  • 项目类别：
    Operating Grants
  • 资助金额：
    $24.52万
  • 财政年份：
    2020
  • 负责人：
    Chan Noel
  • 依托单位：
    McMaster University
海外基金